EGCG inhibited the formation of DMH-induced CRC by regulating key pathways, namely p53 and PI3K-Akt signaling pathways and I-kappaB kinase/NF-kappaB signal pathways, apoptosis signal pathways and MAPK cascades, involved in tumorigenesis [29]. This evidence concerns the gene AKT1 and colorectal carcinoma.